Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
In the latest session, Novartis AG ADR (NYSE: NVS) closed at $138.88 down -0.18% from its previous closing price of $139.13. In other words, the price has decreased by -$0.18 from its previous closing price. On the day, 0.65 million shares were traded. NVS stock price reached its highest trading level at $139.48 during the session, while it also had its lowest trading level at $138.5501.
Ratios:
For a deeper understanding of Novartis AG ADR’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 27.02 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 13.39. For the most recent quarter (mrq), Quick Ratio is recorded 0.68 and its Current Ratio is at 0.88. In the meantime, Its Debt-to-Equity ratio is 0.72 whereas as Long-Term Debt/Eq ratio is at 0.55.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on May 23 ’25 when Marshall Fiona bought 15,000 shares for $112.68 per share.
Kowalski Robert William bought 1,212 shares of NVS for $137,297 on Apr 30 ’25.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NVS now has a Market Capitalization of 266481844224 and an Enterprise Value of 289257848832. As of this moment, Novartis’s Price-to-Earnings (P/E) ratio for their current fiscal year is 18.93, and their Forward P/E ratio for the next fiscal year is 15.18. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.88. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.84 while its Price-to-Book (P/B) ratio in mrq is 6.01. Its current Enterprise Value per Revenue stands at 5.131 whereas that against EBITDA is 11.606.
Stock Price History:
The Beta on a monthly basis for NVS is 0.51, which has changed by 0.4115256 over the last 52 weeks, in comparison to a change of 0.16098404 over the same period for the S&P500. Over the past 52 weeks, NVS has reached a high of $140.18, while it has fallen to a 52-week low of $96.91. The 50-Day Moving Average of the stock is 6.59%, while the 200-Day Moving Average is calculated to be 14.88%.
Shares Statistics:
For the past three months, NVS has traded an average of 1.73M shares per day and 1602200 over the past ten days. A total of 1.92B shares are outstanding, with a floating share count of 1.90B. Insiders hold about 0.01% of the company’s shares, while institutions hold 7.14% stake in the company. Shares short for NVS as of 1765756800 were 5422912 with a Short Ratio of 3.14, compared to 1763078400 on 5426777. Therefore, it implies a Short% of Shares Outstanding of 5422912 and a Short% of Float of 0.27999999999999997.
Dividends & Splits
According to the company, the forward annual dividend rate for NVS is 3.87, from 3.862 in the trailing year. Against a Trailing Annual Dividend Yield of 0.02775821. The stock’s 5-year Average Dividend Yield is 3.6. The current Payout Ratio is 55.42% for NVS, which recently paid a dividend on 2025-03-12 with an ex-dividend date of 2025-03-12. Stock splits for the company last occurred on 2019-04-09 when the company split stock in a 1116:1000 ratio.
Earnings Estimates
Its stock is currently analyzed by 2.0 different market analysts.
Analysts are recommending an EPS of between $9.3 and $8.67 for the fiscal current year, implying an average EPS of $8.93. EPS for the following year is $9.22, with 7.0 analysts recommending between $9.38 and $8.94.
Revenue Estimates
A total of 7 analysts believe the company’s revenue will be $13.81B this quarter.It ranges from a high estimate of $14.46B to a low estimate of $13.6B. As of. The current estimate, Novartis AG ADR’s year-ago sales were $13.56BFor the next quarter, 7 analysts are estimating revenue of $13.99B. There is a high estimate of $14.38B for the next quarter, whereas the lowest estimate is $13.6B.
A total of 19 analysts have provided revenue estimates for NVS’s current fiscal year. The highest revenue estimate was $57.35B, while the lowest revenue estimate was $54.4B, resulting in an average revenue estimate of $55.66B. In the same quarter a year ago, actual revenue was $51.72BBased on 16 analysts’ estimates, the company’s revenue will be $56.97B in the next fiscal year. The high estimate is $58.78B and the low estimate is $54.19B.
